No Data
List of cloud penetration stocks [Ichimoku Kinko Hyo - List of cloud penetration stocks]
○ List of stocks breaking through the clouds Market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <1835> Toei Iron Works 3155 3082.25 3129.5 <1899> Fukuda Corporation 5320 5287.55 127.5 <1946> Toenek 1130 1003.59 97.5 <1964> Chugai Boiler 3780 3752.53 590 <1975> Asahi Corporation 2139 2043.25 213
Spot information for individual stocks (1)
Sumitomo Pharma <4506.T> hits the upper limit. The core operating profit Financial Estimates (consolidated) for the fiscal year ending March 2025 have been raised. Sales of the advanced prostate cancer treatment "Orgovyx" have increased. Komatsu Wall <7949.T> hits the upper limit in buy orders. The consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is 4.1 billion yen (a 12% increase compared to the previous period). The level of Dividends will be raised from 3.0% as the lower limit of DOEs (Return on Equity) to a target of 6%. SMS <2175.T> has risen for nine consecutive days. The consolidated operating profit Financial Estimates for the fiscal year ending March 2026 is...
The Nikkei average rose by 205 yen, extending its gains for five consecutive days, recovering to 36,000 yen at the close for the first time in a month = 30th afternoon session.
On the 30th, the Nikkei average stock price in the afternoon session increased by 205.39 yen to 36,045.38 yen, marking a five-day rise. The TOPIX (Tokyo Stock Price Index) also rose by 16.68 points to 2,667.29 points. The Nikkei average surpassed the psychological barrier of 36,000 yen for the first time in a month since March 28 (37,120.33 yen) on a closing basis. While buying tended to lead in the morning, there were also moments when selling in anticipation of a pullback led to heavier trading. However, as the afternoon session began, the exchange rate temporarily.
Stocks hitting the upper and lower limits before the market.
■ Limit up <4240> Cluster Technology <4506> Sumitomo Pharma ■ Limit down <6836> Plat Home *Includes temporary limit up and down (indicative prices).
Patent Focus = Sumitomo Pharma: Azabicyclo ring derivatives, etc.
Sumitomo Pharma <4506.T> conducts research and development focused on psychiatric and neurological fields as well as cancer. Its main products include the prostate cancer treatment "Orgovix". Optical active azabicyclo ring derivatives (2025060871) that are highly effective anticancer agents, formulations with excellent solubility and tabletability (WO/2025/070617), and a method to non-invasively monitor the state of cells in culture during differentiation from pluripotent stem cells to neural cells in the midbrain floor plate.
The Nikkei average is up by about 20 yen, with the top gainers among the selected stocks being Sumitomo Pharma, TOTO, NEC, ETC.
On the 30th at around 11 AM, the Nikkei Stock Average was trading around 35,860 yen, up about 20 yen compared to the previous trading day. At 9:09 AM, it reached 36,023.24 yen, up 183.25 yen. After the buying frenzy, there were moments of retraction as there were few clues, and the exchange rate was also moving in the direction of a stronger yen. Afterward, it remained in a range near the previous trading day's closing price. Among the stocks listed in the Nikkei Average, Sumitomo Pharma <4506.T> and TOTO <5332> ranked high in terms of price increase percentage.